Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
verywellhealth9h
16 Ways to Get Rid of Eye Bags and Depuff Overnight
Puffy under-eye bags are often related to lifestyle choices, such as smoking or not sleeping enough. Find ways to minimize ...
Le Lézard13h
Teva and Alvotech Announce SELARSDItm (ustekinumab-aekn) Injection Now Available in the U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...
ophthalmologyadvisor3h
Semaglutide Use Modestly Elevates Optic Neuropathy Risk in Patients With Diabetes
Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.